Biology of pulmonary preneoplastic lesions

Cancer Treatment Reviews

Volumn 23, Issue 4, 1997, Pages 241-262

  Vermylen, P ^a   Roufosse, C ^a   Ninane, V ^a   Sculier, J P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; CYTOKERATIN; DNA; PROTEIN TYROSINE KINASE; RETINOIC ACID RECEPTOR; TUMOR MARKER;

APOPTOSIS; BRONCHOSCOPY; BRONCHUS; CAUSE OF DEATH; CELL CYCLE; CELL PROLIFERATION; CHROMOSOME 9P; DNA REPAIR; EARLY DIAGNOSIS; GENE DELETION; HUMAN; IMMEDIATE EARLY GENE; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; LUNG CARCINOGENESIS; LUNG FIBROSIS; ONCOGENE; PAPILLOMA VIRUS; POINT MUTATION; PRECANCER; REVIEW; SIGNAL TRANSDUCTION; SPUTUM ANALYSIS; STRUCTURAL CHROMOSOME ABERRATION; TUMOR SUPPRESSOR GENE;

EID: 0030656269     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(97)90013-X     Document Type: Article

References (136)

1. Thomas, P., Rubinstein, L. and the Lung Cancer Study Group. (1990) Cancer recurrence after resection: T1NO non small cell lung cancer. Ann. Thorac. Surg. 49: 242-247.
2. Saccomanno, G., Archer, V. E., Auerbach, O., Saunders, P. & Brennan, L. (1974) Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 33: 256-270.
3. Saccomanno, G., Saunders, R., Archer, V. E., Auerbach, O., Kuschner, M. & Beckler, P. A. (1965) Cancer of the lung: the cytology of sputum prior to the development of carcinoma. Acta. Cytol. 9: 413-423.
4. Auerbach, O., Stout, A. P. & Hammond, E. C. (1961) Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N. Engl. J. Med. 265: 253-267.
5. Gazdar, A. F. (1994) The molecular and cellular basis of human lung cancer. Anticancer Res. 13: 261-268.
6. Minna, J. D. (1996) Molecular biology overview. In Pass, H. I., Mitchell, J. B., Johnson, J. H. & Turrisi, A. T., eds, Lung Cancer: Principle and Practice. Lippincott-Raven; Philadelphia: Lippincott-Raven, pp. 143-148.
7. Denissenko, M. F., Pao, A., Moon-Shong, T. & Pfeifer, G. T. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hot spots in p53. Science 274: 430-432.
8. Weinberg, R. A. (1989) Oncogenes, antioncogenes and the molecular basis of multistep carcinogenesis Cancer Res. 49: 3713-3721.
9. Weinberg, R. A. (1991) Tumor suppressor genes. Science 254: 1138-1146.
10. Peto, R. (1977) Epidemiology, multistage models and short term mutagenesis tests.In: Hiah H. H., Watson, J. D. & Winsten, J. A., Eds, Origins of Human Cancer New York: Cold Spring Harbor Laboratory, p. 1403.
11. Hunter, T. (1991) Cooperation between oncogenes. Cell 64: 249-270.
12. Fialkow, P. J. (1977) Clonal origin and stem cell evolution of human tumors p 439 in Genetics of human cancer; Mulvihill, J. J., Miller R. M. & Fraumeni J. F., eds Raven Press, New York.
13. Fearon, E. R. & Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
14. Slaughter, D. P., Southwick, H. W. & Smejkal, W. (1954) Field cancerization of oral stratified squamous epithelium: clinical implication of multicentric origin. Cancer 6: 963-968.
15. Woolner, L. B. (1993) Lung in Pathology of Incipient Neoplasia. Henson P. E. & Albores-Saavedra J, eds Second Edition, Sanders Company.
16. Colby, T., Koss, M. & Travis, W. D. Tumor of the lower respiratory tract, Third Series fascicle 13, The Armed Forces Institute of Pathology, Washington, DC.
17. Mc Dowell, E. & Beals T. (1986) Biopsy Pathology of the Bronchi. London: Chapman and Hall.
18. Smith, A. L. Hung, J., Walker, L. et al. (1996) Extensive areas of aneuploidy are present in the respiratory epithelium of lung cancer patients Br. J. Cancer 73: 203-209.
19. Auerbach, O., Hammond, C. & Garfinkel, L. (1979) Changes in bronchial epithelium in relation to cigarette smoking 1955-1960 vs 1970-1977. N. Engl. J. Med. 300(8): 381-386.
20. Carter, D. (1983) Precancer in the lung. Cancer Survey 2(3): 425-435.
21. La Rosa, F. G., Proudfoot, S., Kennedy, T., Miller, Y. & Franklin, W. A. (1996) Micropapillary squamous metaplasia in the bronchial mucosa of smokers. Modern Pathol. 9(1): 159A.
22. Mori, M., Tezuka, F., Chiba, R. et al. (1996) Atypical adenomatous hyperplasia and adenocarcinoma of the lung. Cancer. 77(4): 665-674.
23. Nakanishi, K. (1990) Alveolar epithelial hyperplasia and adenocarcinoma of the lung. Arch. Pathol. Lab. Med. 114: 363-368.
24. Kitamura, H., Kameda, Y., Nakamura, N. et al. (1996) Atypical adenomatous hyperplasia and broncholoalveolar lung carcinoma. Am. J. Surg. Pathol. 20(5): 553-562.
25. Miller, R. (1990) Bronchioloalveolar cell adenomas. Am. J. Surg. Pathol. 14(10): 904-912.
26. Woolner, L. B., Fontana, R. S., Cortese, D. A. et al. (1984) Roengenographically occult lung cancer: Pathologic findings and frequency of multicentricity during a 10 year period. Mayo. Clin. Proc. 59: 453-466.
27. Benner, S. E., Peeters, E., Morice, R. et al. (1992) Squamous metaplasia and dysplasia in bronchial epithelium from heavy smokers: Characteristics of chemoprevention trial intermediate end point. Proc. Am. Soc. Clin. Oncol. 11: 142.
28. Lam, S., Hung, J. C., Kennedy, S. M. et al. (1992) Detection of dysplasia and carcinoma In situ by ratio fluorometry. Am. Rev. Respir. Dis. 146: 1458-1461.
29. Lam, S., MacAulay, C., Hung, J. C., LeRiche, J. C., Profio, A. E. & Palcic, B. (1993) Detection of dysplasia and carcinoma In situ with a lung imaging fluorescence endoscope device. J. Thorac. Cardiovasc. Surg. 105: 1035-1040.
30. Mitsudomi, T., Lam, S., Shirakusa, T. & Gazdar, A. F. (1993) Detection and sequencing of p53 gene mutations in bronchial biopsy samples in patients with lung cancer. Chest. 104: 362-365.
31. Sozzi, G., Miozzo, M., Tagliabue, E. et al. (1991) Cytogenetic abnormalities and overexpression of receptor for growths factor in normal bronchial epithelium and tumor samples of lung cancer patients. Cancer Res. 51: 400-404.
32. Gazdar, A. F., Hung, J., Walker, L., Mikhail, A., Vuitch, K. M. & Smith, A. L (1993) Extensive areas of dysplasia and aneuploidy of the entire bronchial mucosal tract accompanies non small cell lung cancers (NSCLC) and provides evidence for the field of cancerization theory. Proc. Am. Soc. Clin. Oncol. 12: 334.
33. Minna, J. D. (1993) The molecular biology of lung cancer pathogenesis. Chest 103(4): 449S-456S.
34. Thiberville, L., Bourguignon, J., Metayer, J. et al. (1995) Frequency and prognostic evaluation of 3p 21-22 allelic losses in non-small-cell lung cancer. Int. J. Cancer (Pred. Oncol.)64:371-377. 1995
35. Todd, S., Gemmil, L. R., Drabkin, H. & Franklin, W. (1995) Loss of heterozygosity in the short arm of chromosome 3p in small cell lung carcinoma (SCLC) and squamous dysplasia (SD) of bronchial mucosa. Proc. Am. Ass. Cancer Res. 36: 544.
36. Sundaresan, V., Heppell-Parton, A., Coleman, N. et al. (1995) Somatic changes in lung cancer and precancerous lesions. Annals. Oncol. 6: 527-532.
37. Sundaresan, V., Ganly, P., Hasleton, P. et al. (1992) p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene. 7: 1989-1997.
38. Hung, J., Kishimoto, Y., Sugio, K. et al. (1995) Allele specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 7: 558-563.
39. Chung, G. T. Y., Sundaresan, V., Hasleton, P., Rudd, K., Taylor, R. & Rabbitts, P. (1995) Sequential molecular genetic changes in lung cancer development. Oncogene. 11: 2591-2598.
40. Linnoila, R. I., Jensen, S. M., Laskin, W. & Buchhagen, D.L. (1995) Frequent alteration of chromosome 3p in the peripheral lung during pulmonary carcinogenesis in man. Proc. Am. Ass. Cancer Res. 36: 130.
41. Hibi, K., Takahashi, T., Yamakawa. et al. (1992) Three distinct regions involved in 3p deletion in human lung cancer. Oncogene. 7: 445-449.
42. Brauch, H., Tory, K., Kotler, F. et al. (1990) Molecular mapping of deletion sites in the short arm of chromosome 3 in human lung cancer. Genes. Chromosomes Cancer 1: 240-246.
43. Sekido, Y., Bader, S., Latif, F. et al. (1994) Molecular analysis of the Von Hippel-Lindau disease tumor suppressor gene in human lung cancer lines. Oncogene 9: 853-859.
44. Yanagisawa, K., Kondo, M., Osada, H. et al. (1996) Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines. Cancer Res. 56: 5579-5582.
45. Gazdar, A. F. (1996) Early molecular changes in lung cancer. IASLC Prevention and early detection of lung cancer, June 1996, Elsinore
46. Karin, M. (1992) Signal transduction from cell surface to nucleus in development and disease. FASEB J. 6: 2581-2590.
47. Garcia de Palazzo, J. E., Adams, G. P. et al. (1993) Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. Cancer Res. 53: 3217-3220.
48. Hesketh, R. (1995) How are proto oncogenes activated in humans. In Oncogene, Facts Book. London: Academic Press.
49. Schneider, P. M., Hung, M. C., Chiocca, S. M. et al. (1989) Differential expression of the c-erbB-2 gene in human small cell and non small cell lung cancer. Cancer Res. 49: 4968-4971.
50. Yoneda, K., Leslie, D. & Boucher, D. (1993) Bronchial epithelial changes associated with small cell carcinoma of the lung. Hum. Pathol. 24: 1180-1182.
51. Rusch, V., Klimstra, D., Linkov, I. & Dmitrovsky, E. (1995) Aberrant expression of p53 or the epithelial growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development. Cancer Res. 55: 1365-1372.
52. Walker, C., Robertson, L., Dixon, G. & Spedding, A. V. (1994) C-erbB-2 and EGFR expression in normal and dysplastic bronchial epithelium and in lung carcinomas. J. Pathol. 173 (Suppl.): 169A.
53. Kerr, K. M., Carey, F. A., King, G. & Lamb, D. (1994) Atypical alveolar hyperplasia: relationship with pulmonary adenocarcinoma, p53 and C-erbB-2 expression. J. Pathol. 174: 249-256.
54. Lowry, D. R. & Willumsen, B. M. (1993) Function and regulation of ras. Annu. Rev. Biochem. 62: 851-891.
55. Rodenhuis, S., Van Wettering, M. L., Mooi, W. J., Evers, S. G., Van Zandwijk, N. & Bos, J. L. (1987) Mutational activation of the K-Ki-ras oncogene: A possible pathogenetic factor in adenocarcinoma of the lung. N. Engl. J. Med. 317: 929-935.
56. Rodenhuis, S. & Slebos, R. J. C. (1992) Clinical significance of Ki-ras oncogene activation in human lung cancer. Cancer Res. 52: 2665-2669.
57. Rossel, R., Li, S., Skagel, Z. et al. (1993) Prognosis impact of mutated K-Ki-ras gene in surgically resected non small cell lung cancer patients. Oncogene 8: 2407-2412.
58. Sugio, K., Kishmoto, Y., Virmani, A. K., Hung, J. Y. & Gazdar, A. F. (1994) K-ras mutations are relatively late event in the pathogenesis of lung carcinomas. Cancer Res. 54: 5811-5815.
59. Westra, W. H., Boos, I. O., Hruban, R. H. et al. (1996) K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res. 56: 2224-2228.
60. Li, Z. H., Zheng, J., Weiss, L. M. & Shibata, D. (1994) c-Ki-ras and p53 mutations occur very early in adenocarcinoma of the lung. Am. J. Pathol. 144: 303-309.
61. Urban, T., Ricci, S., Lacave, R. et al. (1996) Codon 12 Ki-Ki-ras mutation in non small cell lung cancer: evaluation in tumoural and non tumoural lung. Br. J. Cancer 74: 1051-1055.
62. Yakubowskaya, M. S., Spiegelman, V., Luo, F. C. et al. (1995) High frequency of k-Ki-ras mutation in normal appearing lung tissues and sputum of patients with lung cancer. Int. J. Cancer 63: 810-814.
63. Clements, N. C., Nelson, M. A., Wymer, J. A., Savage, C., Aguirre, M. & Garewal, H. (1995) Analysis of K-Ki-ras gene mutation in malignant and non malignant endobronchial tissue obtained by fiberoptic bronchoscopy. Am. J. Respir. Crit. Care. Med. 152: 1374-1378.
64. Nelson, M. A., Wymers, J. & Clements, N. (1996) Detection of ki-Ras gene mutation in non neoplastic lung tissue and lung cancers. Cancer Letters 103: 115-121.
65. Leid, M., Kastner, P. & Chambon, P. (1992) Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem. Sci. 17: 427-433.
66. Xu, X. C., Lee, J. S., Sozzi, G. et al. (1995) Differential expression of retinoic acid receptor in non small cell lung carcinomas and in bronchial epithelia. Proc. Am. Ass. Cancer Res. 36: 601.
67. Lotan, R., Sozzi, G., Ro, J. et al. (1995) Selective suppression of retinoic acid receptor β (RARβ) expression in squamous metaplasia and in non small cell lung cancer (NSCLC) compared to normal bronchial epithelium. Proc. Am. Soc. Clin. Oncol. 14: 165.
68. Bohman, D., Bos, T., Admon, A., Nishimura, T., Vogt, P. & Tjian, R. (1987) Human protooncogene c-Jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238: 1386-1392.
69. Schuette, J., Nau, M., Birrer, M., Thomas, F., Gazdar, A. F. & Minna, J. D. (1988) Constitutive expression of multiple mRNA forms of the c-Jun oncogene in human lung cancer cell lines. Proc. Am. Ass. Canc. Res. 29: 455.
70. Szabo, E., Riffe, M. E., Steinberg, S. M., Birrer, M. J. & Linnoila, I. R. (1996) Altered c-Jun expression: An early event in human lung carcinogenesis. Cancer Res. 56: 305-315.
71. Treston, A. M., Scott, F. M., Vos, M. et al. (1993) Biochemical characterization of peptide α-amidating activities of human neuro-endocrine lung cancer cell lines. Cell Growth Differ. 4: 911-920.
72. Saldise, L., Martinez, A., Montuenga, L. M. et al. (1996) Distribution of peptidyl glycine α amidating monooxygenase (PAM) enzymes in normal lung and in lung epithelial tumors. J. Histochem. Cytochem. 44: 3-12.
73. Scott, F. M., Treston, M., Shaw, G. L. et al. (1996) Peptide amidating activity in human bronchioloalveolar lavage fluid. Lung Cancer 14: 239-251.
74. Martinez, A., Treston, A. M., Saldise, L., Montuenga, L. M. & Linnoila, R. I. (1996) Expression of peptidyl glycine α-amidating monooxygenase (PAM) enzymes in morphological abnormalities adjacent to pulmonary tumors. Am. J. Pathol. 149: 707-716.
75. Reissmann, P. T., Koga, H., Takahashi, R. et al. (1993) Inactivation of the retinoblastoma susceptibility gene in non small cell lung cancer. Oncogene. 8: 1913-1919.
76. Lees, J. A., Saito, M., Vidal, M. et al. (1993) The retinoblastoma protein binds to a family of E2F Transcription factors. Mol. Cell Biol. 13: 7813-7825.
77. Dixon, G., Salisbury, J. & Walker, C. (1995) Expression of the retinoblastoma protein in normal and dysplastic bronchial epithelium and lung cancer. J. Pathol. 176 (Suppl.) 32A,
78. Lonardo, F., Langenfeld, J., Dmitrovsky, E., Rusch, V. & Klimstra D. S. (1997) Comparative patterns of expression of Cyclin D1, p53 and rB in bronchial preneoplastic lesions. Modern Pathol. 10(1): 167A.
79. Marx, J. (1994) How cells cycle toward cancer. Science. 263: 319-321.
80. Richardson, G. E. & Johnson, B. E. (1993) The biology of lung cancer. Semin. Oncol. 20: 105-127.
81. Hollstein, M., Sidransky, D., Vogelstein, B., Harris, C. (1991) p53 mutations in human cancers. Science. 253: 49-53.
82. Vahakangas, K. H., Samet, J. M., Metcalf, R. A. et al. (1992) Mutations of p53 and Ki-ras gene in radon associated lung cancer from uranium miners. Lancet. 339: 576-580.
83. Sozzi, G., Miozzo, M., Donghi, R. et al. (1992) Deletion of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res. 52: 6079-6082.
84. Klein, N., Vignaud, J. M., Sadmi, M. et al. (1993) Squamous metaplasia expression of protooncogenes and p53 in lung cancer patients. Lab. Invest. 68: 26-32.
85. Bennet, W. P., Colby, T. V., Travis, W. D. et al. (1993) P53 protein accumulates frequently in early bronchial neoplasia. Cancer Res. 53: 4817-4822.
86. Nuorva, K., Saini, Y., Kamel, D. et al. (1993) Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas. Am. J. Pathol. 142: 725-732.
87. Walker, C., Robertson, L. J., Myskow, M. W., Pendleton, N. & Dixon, G. R. (1994) p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas. Br. J. Cancer. 70: 297-303.
88. Hirano, T., Franzen, B., Kato, H., Ebihara, Y. & Auer, G. (1994) Genesis of squamous cell lung carcinoma. Am. J. Pathol. 144: 296-302.
89. Fontanini, G., Vignati, S., Bigini, D. et al. (1994) Human non small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression. J. Pathol. 174: 23-31.
90. Zheng, J., Shu, Q, Li, Z. H., Tsao, J. I., Weiss, L. M. & Shibatta, D. (1994) Pattern of p53 mutations in squamous cell carcinoma of the lung. Am. J. Pathol. 145: 1444-1449.
91. Walker, C., Dixon, G. R. & Myskow, M. (1995) Human non small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression. J. Pathol. 176: 319-324.
92. Boers, J. E., Ten Velde, G. P. M. & Thunnissen B. J. M. (1996) p53 in squamous metaplasia: a marker for risk of respiratory tract carcinoma. Am. J. respir. crit. care med. 153: 411-416.
93. Kitamura, H., Kameda, Y., Nakamura, N. et al. (1995) Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma. Am. J. Pathol. 146: 876-887.
94. Merlo, A., Gabrielson, E., Askin, F. & Sidransky, D. (1996) Frequent loss of chromosome 9 in human primary non small cell lung cancer. Cancer Res. 54: 640-642.
95. Sherr, J. C. (1996) Cancer cell cycles. Science. 274: 1672-1677.
96. INK4a Expression in resected non small cell lung tumors. Cancer Res. 56: 3415-3420.
97. Wiest, J. S., Franklin, W. A., Ostot, J. T. et al. (1997) Identification of a novel region of heterozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: The location of a putative tumor suppressor gene. Cancer Res. 57: 1-6.
98. Kishimoto, Y., Sugio, K., Hung, J. Y. et al. (1995) Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non small cell lung cancers. J. Natl. Cancer. Inst. 87(16): 1224-1229.
99. Garcia, R. C., Caltera, M. D. & Gown, A. M. (1989) Analysis of proliferative grade using PCNA/ Cyclin monoclonal antibodies in fixed embedded tissues: Comparison with flow cytometric analysis. Am. J. Pathol. 134: 733-739.
100. Pendleton, N., Dixon, G. R., Burnett, H. E., Occleston, N. L., Myskow, M. W. & Green, J. A. (1993) Expression of proliferative cell nuclear antigen (PCNA) in dysplasia of the bronchial epithelium. J. Pathol. 170: 169-172.
101. Tomlinson, I. P. M. & Bodmer, W. F. (1995) Failure of programmed cell death and differentiation as causes of tumors: Some simple mathematical models. Proc. Natl. Acad. Sci., USA. 92: 11130-11134.
102. Stewart, B.W. (1994) Mechanisms of apoptosis: Integration of genetic, biochemical and cellular indicators. J. Natl. Cancer. Inst. 86(17): 1286-1296.
103. Brambilla, E., Negoescu, A., Gazzeri, S. et al. (1996) Apoptosis factors p53, Bc12 and Bax in neuroendocrine lung tumors. Am. J. Pathol. 149: 1941-1952.
104. Lu, Q. L., Abel, P., Foster, C. & El-Nasir, L. (1996) Bcl-2: Role in epithelial differentiation and oncogenesis. Hum. Pathol. 27: 102-110.
105. Vaux, D. L., Cory, S. & Adam, J. M. (1988) Bcl-2 gene promotes haemoipoietic cell survival and cooperates with c-myc to immortalize pre-β cells. Nature 335: 440-442.
106. Oltvai, Z. N., Milliman, C. L. & Korsmeyer, S. J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax that accellerates programmed cell death. Cell. 74: 609-619.
107. Walker, C., Robertson, L., Myskow, M. & Dixon, G. (1995) Expression of the Bcl-2 protein in normal and dysplastic bronchial epithelium and in lung carcinoma. Br. J. Cancer. 72: 164-169.
108. Zhang, H., Yousem, S. A., Elder, E. et al. (1996) Expression of wild type p53, mutant p53, Bcl-2 and apoptosis during lung carcinogenesis and in non small cell lung cancer. Proc. Am. Ass. Cancer. Res. 37: 26.
109. Bachetti, S. & Counter, C. M. (1995) Telomeres and telomerase in human cancer. Int. J. Oncol. 7: 423-432.
110. Rhyu, M. S. (1995) Telomeres, telomerase and immortality. J. Natl. Cancer. Inst. 87: 884-894
111. Hyama, A., Hyama, E., Ishioka, S. et al. (1995) Telomerase activity in small and non small cell lung cancers. J. Natl. Cancer. Inst. 87: 895-902.
112. Moll, R., Franke, W. W. & Schiller, D. L. (1982) The catalog of human cytokeratins: pattern of expression in normal epithelia, tumours and cultured cells. Cell. 31: 11-24.
113. Fisseler-Eckhoff, A., Erfkamp, S. & Müller, K. M. (1996) Cytokeratin expression in preneoplastic lesions and early squamous cell carcinoma of the bronchi. Path. Res. Pract. 192: 552-559.
114. Pendleton, N., Dixon, G. R., Green, J. A. & Myskow, M. W. (1996) Expression of markers of differentiation in normal bronchial epithelium and bronchial dysplasia. J. Pathol. 178: 146-150.
115. Penno, M. B., August, J. T., Baylin, S. B. et al. (1994) Expression of CD 44 in human lung tumors. Cancer Res. 54: 1381-1387.
116. Fisseler-Eckhoff, A., Rothstein, D. & Müller, K. M. (1996) Neovascularization in hyperplastic, metaplastic and potentially preneoplastic lesions of the bronchial mucosa. Virchow Arch. 429: 95-100.
117. Fontanini, G., Vignati, S., Bigini, D. et al. (1996) Neoangiogenesis: a putative marker of malignancy in non small cell lung cancer (NSCLC) development. Int. J. Cancer. 67: 615-619.
118. Matrisian, L. M. (1992) The matrix degrading metalloproteinases. Bioessays. 14: 455-462.
119. Urbanski, S. J., Edwards, D. R., Maitland, A., Leco, K. J., Watson, A. & Kossakowska, A. E. (1992) Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br. J. Cancer. 66: 1188-1194.
120. Bolon, I., Brambilla, E., Vandenbunder, B., Robert, C., Lantuejoul, S. & Brambilla C. (1996) Changes in the expression of matrix proteases and the transcription of factor c-Ets-1 during progression of precancerous bronchial lesions. Lab. Invest. 75(1): 1-13.
121. Hollas, W., Blasi, F. & Boyd, D. (1991) Role of urokinase receptor in facilitating extracellular invasion by cultured colon cancer. Cancer Res. 51: 3690-3695.
122. Fisseler-Eckhoff, A., Presberg, M., Voss, B. & Müller, K. M. (1990) Extracellular matrix in preneoplastic lesions and early cancer of the lung. Path. Res. Pract. 186: 95-101.
123. Mao, L., Lee, D., Tockman, M., Erozan, Y., Askin, J. & Sidransky, D. (1994) Microsatellite alterations as clonal markers for the detection of human cancer. Proc. Natl. Acad. Sci. U.S.A. 91:9871-9875
124. Miozzo, M., Sozzi, G., Mussa, K. et al. (1996) Microsatellite alteration in bronchial and sputum specimens of lung cancer patients. Cancer Res. 56: 2285-2288.
125. Hirayasu, T., Iwamasa, T., Kamada, Y., Koyanagi, Y., Usuda, H. & Genka, K. (1996) Human papillomavirus DNA in squamous cell carcinoma of the lung. J. Clin. Pathol. 49: 810-817.
126. Nuorva, K., Soini, Y., Kamel, D. et al. (1995) p53 protein accumulation and the presence of human papillomavirus DNA in bronchiolo-alveolar carcinoma correlate with poor prognosis. Int. J. Cancer (Pred. Oncol). 64: 424-429.
127. Yousem, S. A., Ohori, N. P. & Sonmez-Alpon, E. (1992) Occurrence of human papillomavirus DNA in primary lung neoplasms. Cancer. 69: 693-697.
128. Sozzi, G., Miozzo, M., Pastorino, U. et al. (1995) Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res. 55: 135-140.
129. Thiberville, L., Payne, P., Vielkinds, J. et al. (1995) Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Cancer Res. 55: 5133-5139.
130. Thiberville, L., Payne, P., Metayer, J. et al. Molecular follow up of a preinvasive bronchial lesion treated by 13-cis retinoic acid. Human Pathol. 28(1): 108-110.
131. Jensen, S. M., Jones, J. E., Pass, H., Steinberg, S. M. & Linnoila, R. I. (1994) Clara cell 10 kDa protein mRNA in normal and atypical regions of human respiratory epithelium. Int. J. Cancer. 58: 629-637.
132. Horio, Y., Takahashi, T., Kuroishi, T. et al. (1993) Prognostic significance of p53 mutations and 3p deletions in primary resected non small cell lung cancer. Cancer Res. 53: 1-4.
133. Pezzela, F., Turley, H., Kuzu, I. et al. (1993) Bcl-2 Protein in non small cell lung cancer. N. Engl. J. Med. 329: 690-694.
134. Smit, E. F., Groen, H. J. M., Splinter, T. A. U., Ebels, T. & Postmus, P. E. (1996) New prognostic factors in resectable Non small cell lung cancer. Thorax 51: 638-646.
135. Mills, N. E., Fishman, C. L., Scholes, J., Anderson, S. E., Rom, W. N. & Jacobson, D. R. (1995) Detection of K-ras mutation in bronchoalveolar lavage fluid for lung cancer diagnosis. J. Natl. Cancer Inst. 87(14): 1056-1060.
136. Mao, L., Hruban, R. H., Boyle, J. O., Tockman, M. & Sidransky, D. (1994) Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res. 54: 1634-1637.